Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jan 30;14(3):620.
doi: 10.3390/nu14030620.

The Ketogenic Diet: Is It an Answer for Sarcopenic Obesity?

Affiliations
Review

The Ketogenic Diet: Is It an Answer for Sarcopenic Obesity?

Zahra Ilyas et al. Nutrients. .

Abstract

This review aims to define the effectiveness of the ketogenic diet (KD) for the management of sarcopenic obesity. As the combination of sarcopenia and obesity appears to have multiple negative metabolic effects, this narrative review discusses the effects of the ketogenic diet as a possible synergic intervention to decrease visceral adipose tissue (VAT) and fatty infiltration of the liver as well as modulate and improve the gut microbiota, inflammation and body composition. The results of this review support the evidence that the KD improves metabolic health and expands adipose tissue γδ T cells that are important for glycaemia control during obesity. The KD is also a therapeutic option for individuals with sarcopenic obesity due to its positive effect on VAT, adipose tissue, cytokines such as blood biochemistry, gut microbiota, and body composition. However, the long-term effect of a KD on these outcomes requires further investigations before general recommendations can be made.

Keywords: cytokine; fatty liver; gut microbiota; ketogenic diet; physical inactivity; sarcopenia; visceral adipose tissue (VAT).

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Similar articles

Cited by

References

    1. Prado C.M.M., Wells J.C.K., Smith S.R., Stephan B.C.M., Siervo M. Sarcopenic obesity: A Critical appraisal of the current evidence. Clin. Nutr. 2012;31:583–601. - PubMed
    1. Barazzoni R., Bischoff S.C., Boirie Y., Busetto L., Cederholm T., Dicker D., Toplak H., Van Gossum A., Yumuk V., Vettor R. Sarcopenic obesity: Time to meet the challenge. Clin. Nutr. 2018;37:1787–1793. doi: 10.1016/j.clnu.2018.04.018. - DOI - PubMed
    1. Alalwan T.A. Phenotypes of Sarcopenic Obesity: Exploring the Effects on Peri-Muscular Fat, the Obesity Paradox, Hormone-Related Responses and the Clinical Implications. Geriatrics. 2020;5:8. doi: 10.3390/geriatrics5010008. - DOI - PMC - PubMed
    1. Collins K.H., Paul H.A., Hart D.A., Reimer R.A., Smith I.C., Rios J.L., Seerattan R.A., Herzog W. A High-fat high-sucrose diet rapidly alters muscle integrity, inflammation, and gut microbiota in male rats. Sci. Rep. 2016;6:37278. - PMC - PubMed
    1. Hashimoto Y., Nakao C., Yamazaki R., Hiroyama H., Nemoto H., Yamamoto T., Sakurai S., Oike M., Wada H., Yoshida N., et al. Short-term feeding at the wrong time is sufficient to desynchronize peripheral clocks and induce obesity with hyperphagia, physical inactivity and metabolic disorders in mice. Metabolism. 2016;65:714–727. - PubMed